AGP Executive Report
Last update: 3 hours agoDermatology: The UAE says it has become the first country to approve an oral treatment for vitiligo, announced at a regional dermatology conference. Physician Pay: CMS finalized its 2027 Medicare fee schedule, cutting physician conversion rates by 1.83% for qualifying advanced-payment-model clinicians and 2.31% for others, while expanding some payments for primary care provided by residents. Clinical Technology: Belfast-based PulseAI won FDA clearance for software that analyzes ECG readings from wearables, opening a path to U.S. clinical use. NHS Workforce: England’s care boards are cutting roughly a third of staff to reduce costs; the National Audit Office warned that rapid restructuring could leave them without the skills needed to commission services effectively. Drug Access: Gilead says China is reviewing lenacapavir, a twice-yearly HIV-prevention injection, and seladelpar for primary biliary cholangitis; both are already available to some patients through special-access programs.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.